Published in Clin Lab Med on December 01, 2002
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Human prion diseases in the United States. PLoS One (2010) 1.03
BSE safety standards: An evaluation of public health policies of Japan, Europe, and USA. Environ Health Prev Med (2005) 0.75
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol (2013) 1.42
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J (2010) 1.17
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology (2005) 1.08
Re: Examining the Association Between Kawasaki Disease and Pertussis. Epidemiology (2015) 1.07
Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab (2011) 1.06
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis (2008) 1.05
Human prion diseases in the United States. PLoS One (2010) 1.03
Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J (2002) 1.02
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One (2010) 1.00
Kawasaki disease and human coronavirus. J Infect Dis (2005) 0.97
An evaluation of hospitalizations for Kawasaki syndrome in Georgia. Arch Pediatr Adolesc Med (2002) 0.97
Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein. J Biol Chem (2005) 0.96
Barriers to Creutzfeldt-Jakob disease autopsies, California. Emerg Infect Dis (2004) 0.96
Transfusion transmission of human prion diseases. Transfus Med Rev (2008) 0.95
Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis (2005) 0.94
Infectious disease hospitalizations among older American Indian and Alaska Native adults. Public Health Rep (2007) 0.92
Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000. Pediatr Infect Dis J (2003) 0.92
Guillain-barré syndrome following influenza vaccination: causal or coincidental? Curr Infect Dis Rep (2011) 0.88
Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.88
Barriers to autopsy: Creutzfeldt-Jakob disease in New York state. Neuroepidemiology (2006) 0.88
Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis (2015) 0.86
Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion (2009) 0.85
Creutzfeldt-Jakob disease in recipients of corneal transplants. Cornea (2008) 0.84
Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005. Neuroepidemiology (2010) 0.83
An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: challenges and lessons learned. Infect Control Hosp Epidemiol (2006) 0.81
Disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol (2010) 0.81
Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg Infect Dis (2012) 0.81
Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Acta Paediatr (2013) 0.80
Transmissible spongiform encephalopathies. J Am Vet Med Assoc (2008) 0.79
Travel history, hunting, and venison consumption related to prion disease exposure, 2006-2007 FoodNet Population Survey. J Am Diet Assoc (2011) 0.79
Variant Creutzfeldt-Jakob disease death, United States. Emerg Infect Dis (2005) 0.79
Hospital charges attributable to a primary diagnosis of infectious diseases in older adults in the United States, 1998 to 2004. J Am Geriatr Soc (2008) 0.79
Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone. Emerg Infect Dis (2013) 0.77
Kawasaki disease hospitalization rate among children younger than 5 years in California, 2003-2010. Pediatr Infect Dis J (2014) 0.77
Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep (2003) 0.76
Etymologia: prion. Emerg Infect Dis (2012) 0.75
Clinical assessment of self-reported acute flaccid paralysis in a population-based setting in Guatemala. Am J Trop Med Hyg (2010) 0.75
Reply: To PMID 22565293. Pediatr Infect Dis J (2013) 0.75
Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report. BMC Neurol (2011) 0.75
Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines. BMJ (2011) 0.75
Sporadic fatal insomnia in an adolescent. Pediatrics (2014) 0.75
Reply to Smyth et al. Infect Control Hosp Epidemiol (2014) 0.75
A case of Creutzfeldt-Jakob disease associated with a dura mater graft in the United States. Infect Control Hosp Epidemiol (2007) 0.75
Intracranial Procedures and Expected Frequency of Creutzfeldt-Jakob Disease. Neuroepidemiology (2015) 0.75
Investigation of a possible iatrogenic case of Creutzfeldt-Jakob disease after a neurosurgical procedure. Infect Control Hosp Epidemiol (2006) 0.75